Progesterone activates GPR126 to promote breast cancer development via the Gi pathway.
Progesterone activates GPR126 to promote breast cancer development via the Gi pathway.
复制标题
黄体酮通过 Gi 通路激活 GPR126 促进乳腺癌发生
DOI:
10.1073/pnas.2117004119
复制
发表时间:
2022-04-12
影响因子:
11.1
通讯作者:
中科院分区:
文献类型:
--
作者:
The steroid hormone progesterone is highly involved in different physiological–pathophysiological processes, including bone formation and cancer progression. Understanding the working mechanisms, especially identifying the receptors of progesterone hormones, is of great value. In the present study, we identified GPR126 as a membrane receptor for both progesterone and 17-hydroxyprogesterone and triggered its downstream G protein signaling. We further characterized the residues of GPR126 that interact with these two ligands and found that progesterone promoted the progression of a triple-negative breast cancer model through GPR126-dependent Gi-SRC signaling. Therefore, developing antagonists targeting GPR126-Gi may provide an alternative therapeutic option for patients with triple-negative breast cancer. GPR126 is a member of the adhesion G protein-coupled receptors (aGPCRs) that is essential for the normal development of diverse tissues, and its mutations are implicated in various pathological processes. Here, through screening 34 steroid hormones and their derivatives for cAMP production, we found that progesterone (P4) and 17-hydroxyprogesterone (17OHP) could specifically activate GPR126 and trigger its downstream Gi signaling by binding to the ligand pocket in the seven-transmembrane domain of the C-terminal fragment of GPR126. A detailed mutagenesis screening according to a computational simulated structure model indicated that K1001ECL2 and F1012ECL2 are key residues that specifically recognize 17OHP but not progesterone. Finally, functional analysis revealed that progesterone-triggered GPR126 activation promoted cell growth in vitro and tumorigenesis in vivo, which involved Gi-SRC pathways in a triple-negative breast cancer model. Collectively, our work identified a membrane receptor for progesterone/17OHP and delineated the mechanisms by which GPR126 participated in potential tumor progression in triple-negative breast cancer, which will enrich our understanding of the functions and working mechanisms of both the aGPCR member GPR126 and the steroid hormone progesterone.
登录
查看更多内容
影响因子:
44.1
作者:
Fu Y;Huang Y;Yang Z;Chen Y;Zheng J;Mao C;Li Z;Liu Z;Yu B;Li T;Wang M;Xu C;Zhou Y;Zhao G;Jia Y;Guo W;Jia X;Zhang T;Li L;Liu Z;Guo S;Ma M;Zhang H;Liu B;Du J;Wang W;Tang C;Gao P;Xu Q;Wang X;Liu J;Sun J;Kong W
通讯作者:
Kong W
影响因子:
4.6
作者:
Kou I;Watanabe K;Takahashi Y;Momozawa Y;Khanshour A;Grauers A;Zhou H;Liu G;Fan YH;Takeda K;Ogura Y;Zhou T;Iwasaki Y;Kubo M;Wu Z;Matsumoto M;Japan Scoliosis Clinical Research Group (JSCRG);Texas Scottish Rite Hospital for Children Clinical Group (TSRHCCG);Einarsdottir E;Kere J;Huang D;Qiu G;Qiu Y;Wise CA;Song YQ;Wu N;Su P;Gerdhem P;Ikegawa S
通讯作者:
Ikegawa S
影响因子:
3.7
作者:
Kitagaki J;Miyauchi S;Asano Y;Imai A;Kawai S;Michikami I;Yamashita M;Yamada S;Kitamura M;Murakami S
通讯作者:
Murakami S
影响因子:
16.6
作者:
Soler Artigas M;Wain LV;Miller S;Kheirallah AK;Huffman JE;Ntalla I;Shrine N;Obeidat M;Trochet H;McArdle WL;Alves AC;Hui J;Zhao JH;Joshi PK;Teumer A;Albrecht E;Imboden M;Rawal R;Lopez LM;Marten J;Enroth S;Surakka I;Polasek O;Lyytikäinen LP;Granell R;Hysi PG;Flexeder C;Mahajan A;Beilby J;Bossé Y;Brandsma CA;Campbell H;Gieger C;Gläser S;González JR;Grallert H;Hammond CJ;Harris SE;Hartikainen AL;Heliövaara M;Henderson J;Hocking L;Horikoshi M;Hutri-Kähönen N;Ingelsson E;Johansson Å;Kemp JP;Kolcic I;Kumar A;Lind L;Melén E;Musk AW;Navarro P;Nickle DC;Padmanabhan S;Raitakari OT;Ried JS;Ripatti S;Schulz H;Scott RA;Sin DD;Starr JM;UK BiLEVE;Viñuela A;Völzke H;Wild SH;Wright AF;Zemunik T;Jarvis DL;Spector TD;Evans DM;Lehtimäki T;Vitart V;Kähönen M;Gyllensten U;Rudan I;Deary IJ;Karrasch S;Probst-Hensch NM;Heinrich J;Stubbe B;Wilson JF;Wareham NJ;James AL;Morris AP;Jarvelin MR;Hayward C;Sayers I;Strachan DP;Hall IP;Tobin MD
通讯作者:
Tobin MD
影响因子:
3.5
作者:
Diep CH;Daniel AR;Mauro LJ;Knutson TP;Lange CA
通讯作者:
Lange CA